NNC 45-0095
跳转到导航
跳转到搜索
| File:NNC 45-0095.svg | |
| 临床资料 | |
|---|---|
| 其他名称 | NNC-450095 |
| 药物类别 | 选择性雌激素受体调节物 |
| 识别信息 | |
| |
| CAS号 | 217318-90-6 |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| E编码 | {{#property:P628}} |
| CompTox Dashboard (EPA) |
|
| ECHA InfoCard | {{#property:P2566}}Module:EditAtWikidata第29行Lua错误:attempt to index field 'wikibase' (a nil value) |
| 化学信息 | |
| 化学式 | C18H15NO |
| 摩尔质量 | 261.32 g·mol−1 |
| 3D模型(JSmol) | |
| |
| |
NNC 45-0095是一种含氮有机化合物,化学式C18H17NO,可作为非甾体选择性雌激素受体调节物(SERMs),由诺和诺德开发,用于治疗骨质疏松症,从未上市销售。[1][2][3][4][5]
参考文献[编辑]
- ^ Jørgensen AS, Jacobsen P, Christiansen LB, Bury PS, Kanstrup A, Thorpe SM, et al. Synthesis and pharmacology of a novel pyrrolo[2,1,5-cd] indolizine (NNC 45-0095), a high affinity non-steroidal agonist for the estrogen receptor. Bioorganic & Medicinal Chemistry Letters. February 2000, 10 (4): 399–402. PMID 10714509. doi:10.1016/S0960-894X(00)00015-9.
- ^ Sharma V, Kumar V. Indolizine: a biologically active moiety. Medicinal Chemistry Research. 2014, 23 (8): 3593–3606. ISSN 1054-2523. S2CID 2643469. doi:10.1007/s00044-014-0940-1.
- ^ Wallace OB, Richardson TI, Dodge JA. Estrogen receptor modulators: relationships of ligand structure, receptor affinity and functional activity. Current Topics in Medicinal Chemistry. 2003, 3 (14): 1663–1682. PMID 14683521. doi:10.2174/1568026033451727.
- ^ Meegan MJ, Lloyd DG. Understanding the Molecular Mechanism of Action of Estrogen Receptor Modulators. Frontiers in Medicinal Chemistry-Online. Atta-ur-Rahman, Reitz AB (编). Frontiers in Medicinal Chemistry 2. Bentham Science Publishers. January 2005: 183–231 (206). ISBN 978-1-60805-205-9.
|issue=被忽略 (帮助) - ^ NNC 450095. AdisInsight. Springer Nature Switzerland AG. [2024-01-18]. (原始内容存档于2024-01-18).